Albany, New York, July 20, 2017: The decrease in opioid prescriptions is expected to result in augmented use of non-opioid procedures for treating ailments thereby driving expansion in the non-opioid pain patch market. Also, the increasing prevalence of pain-related disorders and rising global spending on pain management treatments is likely to contribute to the growth of the global non-opioid pain patch market. Considering this aspect, a new research report with a title “Non-opioid Pain Patch Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” has been recently added to the vast online repository of Market Research Reports Search Engine (MRRSE). This report on non-opioid pain patch market analyzes its current status as well as future prospects of the industry across the globe.
The global non-opioid pain patch market is expected to grow at a CAGR of 3.3% between 2016 and 2024. Expanding at this pace, the market will reach a valuation of US$4,983.3 million by 2024 from US$3,750 million in 2015. The report comprises a comprehensive analysis of the overall non-opioid pain patch market identifying the market dynamics such as drivers, restraints, risks and opportunities, along with market attractiveness analysis and Porter’s five force analysis. Besides this, market opportunities analysis for the global non-opioid pain patch market has also been provided. Major industrial developments including the key events occurred in recent times and are expected to occur during the forecast period are analyzed within the report. The WHO pain ladder for pain management treatment is also included, along with the percentage occurrence rates of acute pain by region and by countries.
The global non-opioid pain patch market is segregated on the basis of patch type, and distribution channels. Based on patch type, the global non-opioid pain patch market is segmented into methyl salicylate patches, lidocaine patches, diclofenac patches, capsaicin patches, ketoprofen patches, and others. Likewise, on the basis of distribution channels, the global non-opioid pain patch market is categorized as online pharmacies, hospital pharmacies and independent pharmacies & drug stores. Geographically, the non-opioid pain patch market is classified into five segments namely, Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.
Finally, the report also provides a section on the competitive landscape analysis, in which the market share analysis of top players in the global market is provided, in terms of percentage share in 2016. The report concludes with the profiles of key players in the global non-opioid pain patch market such as ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.,Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., Acorda Therapeutics, Inc., IBSA Institut Biochimque SA, Mylan N.V. , Pfizer, Inc., and Teikoku Seiyaku Co., Ltd., among others. These companies are assessed on various parameters such as financial overview, company overview, product offering, business strategies and recent developments.
Browse Full Global Non-opioid Pain Patch Market Report with TOC : http://www.mrrse.com/non-opioid-pain-patch-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207